Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the national cancer research institute CLL206 trial
| Image |  |
|---|---|
| Description | scientific article published on 09 April 2012 |
| Author/s |
author: Daniel Catovsky Claire E. Dearden Estella Matutes T. J. Hamblin George Alexander Follows David Allsup Andy C Rawstron Melanie Oates David G Oscier John Radford Peter Hillmen Stephen Devereux Andrew R. Pettitt |
| Publication date | April 9, 2012 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |